322 related articles for article (PubMed ID: 32077253)
41. Multidisciplinary therapy including proton beam radiotherapy for a Ewing sarcoma family tumor of maxillary sinus in a 4-year-old girl.
Yamaoka M; Akiyama M; Yokokawa Y; Terao Y; Yokoi K; Kato T; Fukushima T; Sakurai H; Ida H
Head Neck; 2013 Dec; 35(12):E386-90. PubMed ID: 23606421
[TBL] [Abstract][Full Text] [Related]
42. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.
Dirksen U; Brennan B; Le Deley MC; Cozic N; van den Berg H; Bhadri V; Brichard B; Claude L; Craft A; Amler S; Gaspar N; Gelderblom H; Goldsby R; Gorlick R; Grier HE; Guinbretiere JM; Hauser P; Hjorth L; Janeway K; Juergens H; Judson I; Krailo M; Kruseova J; Kuehne T; Ladenstein R; Lervat C; Lessnick SL; Lewis I; Linassier C; Marec-Berard P; Marina N; Morland B; Pacquement H; Paulussen M; Randall RL; Ranft A; Le Teuff G; Wheatley K; Whelan J; Womer R; Oberlin O; Hawkins DS;
J Clin Oncol; 2019 Dec; 37(34):3192-3202. PubMed ID: 31553693
[TBL] [Abstract][Full Text] [Related]
43. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
[TBL] [Abstract][Full Text] [Related]
44. A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893.
Felgenhauer JL; Nieder ML; Krailo MD; Bernstein ML; Henry DW; Malkin D; Baruchel S; Chuba PJ; Sailer SL; Brown K; Ranganathan S; Marina N
Pediatr Blood Cancer; 2013 Mar; 60(3):409-14. PubMed ID: 23065953
[TBL] [Abstract][Full Text] [Related]
45. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P
Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805
[TBL] [Abstract][Full Text] [Related]
46. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
Nesbit ME; Gehan EA; Burgert EO; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P; Askin FB; Kissane JM
J Clin Oncol; 1990 Oct; 8(10):1664-74. PubMed ID: 2213103
[TBL] [Abstract][Full Text] [Related]
47. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
[TBL] [Abstract][Full Text] [Related]
48. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
Arndt CA; Nascimento AG; Schroeder G; Schomberg PJ; Neglia JP; Sencer SF; Silberman TL; Moertel CL; Tillisch JK; Miser JS
Eur J Cancer; 1998 Jul; 34(8):1224-9. PubMed ID: 9849484
[TBL] [Abstract][Full Text] [Related]
49. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Kushner BH; Meyers PA
J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
[TBL] [Abstract][Full Text] [Related]
50. Results of multimodal therapy in Ewing's sarcoma: a retrospective analysis of 20 patients.
Ben-Arush M; Kuten A; Perez-Nahum M; Cohen Y; Bialik V
J Surg Oncol; 1991 Sep; 48(1):51-5. PubMed ID: 1890840
[TBL] [Abstract][Full Text] [Related]
51. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
[TBL] [Abstract][Full Text] [Related]
52. [Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy].
Peng RJ; Sun XF; Xiang XJ; Zhen ZJ; Ling JY; Tong GL; Xia Y; Xu GC; Jiang WQ
Ai Zheng; 2009 Dec; 28(12):1304-9. PubMed ID: 19958626
[TBL] [Abstract][Full Text] [Related]
53. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.
Evans RG; Nesbit ME; Gehan EA; Garnsey LA; Burgert O; Vietti TJ; Cangir A; Tefft M; Thomas P; Askin FB
J Clin Oncol; 1991 Jul; 9(7):1173-80. PubMed ID: 2045857
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Bacci G; Ferrari S; Bertoni F; Rimondini S; Longhi A; Bacchini P; Forni C; Manfrini M; Donati D; Picci P
J Clin Oncol; 2000 Jan; 18(1):4-11. PubMed ID: 10623687
[TBL] [Abstract][Full Text] [Related]
55. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Bhatia S; Krailo MD; Chen Z; Burden L; Askin FB; Dickman PS; Grier HE; Link MP; Meyers PA; Perlman EJ; Rausen AR; Robison LL; Vietti TJ; Miser JS
Blood; 2007 Jan; 109(1):46-51. PubMed ID: 16985182
[TBL] [Abstract][Full Text] [Related]
56. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection.
Shamberger RC; Laquaglia MP; Krailo MD; Miser JS; Pritchard DJ; Gebhardt MC; Healey JH; Tarbell NJ; Fryer CJ; Meyers PA; Grier HE
J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1154-61. PubMed ID: 10838532
[TBL] [Abstract][Full Text] [Related]
57. Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.
Takenaka S; Naka N; Obata H; Joyama S; Hamada K; Imura Y; Kakunaga S; Aoki Y; Ueda T; Araki N; Yoshikawa H
Jpn J Clin Oncol; 2016 Jun; 46(6):522-8. PubMed ID: 27008849
[TBL] [Abstract][Full Text] [Related]
58. Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma.
DuBois SG; Grier HE
Nat Rev Clin Oncol; 2009 May; 6(5):251-3. PubMed ID: 19390548
[TBL] [Abstract][Full Text] [Related]
59. Multimodal therapy for children and adolescents with Ewing sarcoma: results of the First National Chilean Trial (1986-1991).
Villarroel M; Tordecilla J; Salgado C; Luo X; Messen S; Rayo Y; Zolezzi P; Rojas J
Med Pediatr Oncol; 1997 Sep; 29(3):190-6. PubMed ID: 9212843
[TBL] [Abstract][Full Text] [Related]
60. Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors.
Nakao T; Fukushima H; Fukushima T; Suzuki R; Hosaka S; Yamaki Y; Kobayashi C; Iwabuchi A; Imagawa K; Sakai A; Shinkai T; Masumoto K; Sakashita S; Masumoto T; Mizumoto M; Sumazaki R; Sakurai H
Rep Pract Oncol Radiother; 2018; 23(5):442-450. PubMed ID: 30197580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
